SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a preliminary fiscal update that revealed record order intake and a substantial margin expansion, effectively quieting near-term concerns regarding profitability. Investors are now actively debating whether the stock's improved fundamentals can sustain this momentum and fuel a potential short squeeze, given the high level of short interest.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is currently a focal point for investors weighing its long-term potential as an AI data licensing platform against concerns regarding traffic sustainability and potential friction with search engine partners. The community remains deeply divided, with bulls pointing to robust growth in self-service advertising and unique human-generated data, while bears caution against overvaluation and the risk of traffic volatility.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is trending following a better-than-expected earnings report that beat profit expectations, driven by strong growth in fiber and wireless subscribers. Community discussion highlights investor confidence in the company's foundational role in AI-ready infrastructure and accelerated share repurchases, despite ongoing market noise regarding competitive threats.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Investors are closely monitoring Alphabet ahead of its upcoming earnings report, with community sentiment largely focused on the sustainability of massive AI capital expenditures and their impact on cloud growth. Debate persists over whether the stock will face significant volatility due to high expectations for AI monetization or remain a long-term powerhouse in the tech sector.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following reports that Microsoft will deploy its new Helios AI infrastructure, fueling speculation about a major upcoming Anthropic partnership ahead of the company's Advancing AI event. While investors are debating whether these hyperscaler wins signal a continued breakout or are already priced in, the community remains intensely focused on the stock's volatility and its competitive positioning against Nvidia.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is drawing significant investor interest and volatility as markets weigh mixed quarterly results against an aggressive upward revision of long-term guidance, driven by a massive $176 billion backlog and surging AI data center power demand. While the stock has faced near-term profit-taking and technical selling, the community remains heavily focused on the company's role as a critical infrastructure bottleneck, with many investors actively adding to positions on dips as a long-term play on global electrification.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is seeing massive, record-breaking trading volume driven by bullish sentiment surrounding new defense orders and growing institutional interest. The community is actively discussing the stock's potential for a short squeeze, citing high short interest and anticipation for upcoming earnings to validate the company's long-term growth story.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is capturing significant community attention as it secures a central role in U.S. government quantum sensing and defense initiatives, recently appearing before Congress to advocate for critical mineral mapping technology. While the broader market volatility has pressured the share price, bulls are highlighting the company's strong cash position and strategic partnerships with major tech and defense entities as indicators of long-term upside.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following positive Phase 3 topline results for plozasiran in patients with severe hypertriglyceridemia, which demonstrated significant triglyceride reduction and a clear safety profile. Community discussion is heavily focused on the drug's blockbuster potential, the competitive landscape regarding other industry players, and excitement surrounding the company's robust pipeline and future catalysts.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is experiencing significant momentum ahead of upcoming late-breaking clinical trial presentations at ASCO, which investors view as a pivotal catalyst for its lead oncology asset, ivonescimab. While some market skepticism persists regarding trial data comparisons, the community remains intensely focused on the potential for this bispecific antibody to challenge standard-of-care immunotherapy in the lung cancer space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why CELC Stock Declined 15% in a Week Despite a Major FDA Win

Celcuity slides 15% despite FDA approval of Revtorpyk as investors focus on a late Q3 2026 launch that delays commercial sales and near-term revenues.

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know

Astrazeneca (AZN) closed the most recent trading day at $164.52, moving 2.59% from the previous trading session.

SLN Stock Skyrockets 107% in Six Months: Here's What You Need to Know

Silence Therapeutics shares surge as investors eye key 2026 divesiran data, an advancing RNAi pipeline and progress across multiple siRNA programs.

AstraZeneca (AZN) Securities Investigation Notice - Levi & Korsinsky

AstraZeneca (AZN) Securities Investigation Notice - Levi & Korsinsky AstraZeneca (AZN) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, July 16, 2026 AstraZeneca (AZN) shares fell roughly 8% as the market opened on July 9, 2026. Investors who held AZN and lost money are...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN PR Newswire NEW YORK, July 16, 2026 NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is...

AZN Inks Deal With Dizal to In-License Rights to Lung Cancer Drug

AstraZeneca is licensing Zegfrovy from Dizal in a deal worth up to $1.5B, expanding its lung cancer portfolio with a marketed EGFR therapy.

Here's How Pfizer's Oncology Growth Story Looks Ahead of Q2 Results

PFE's oncology business is in focus ahead of Q2 results as growth from key cancer drugs, biosimilars and pipeline updates may offset declines in older therapies.

AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN)

On July 9, 2026, AstraZeneca (NYSE: AZN) stock fell more than 8% premarket after the Company announced that the Phase III CARDIO-TTransform trial of Wainua missed its primary endpoint in ATTR cardiomyopathy. If you suffered a loss on your AstraZeneca investment, you are encouraged to submit your...

Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts

The latest trading day saw Astrazeneca (AZN) settling at $171.61, representing a -3.85% change from its previous close.

How a Rival's Clinical Setback Sent BBIO Stock to a 52-Week High

BridgeBio Pharma hit a 52-week high after a rival's phase III setback boosts confidence in Attruby's competitive position in ATTR-CM.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

BBIO Stock Surges 16% As AstraZeneca-Ionis Heart Drug Trial Misses Goal — BofA Calls Failure ‘A Big Surprise’

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AZNAstraZeneca PLC

Fundamentals

Latest AZN News